These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2794863)
21. Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients. Zineldeen DH; Keshk WA; Ghazy AH; El-Barbary AM Ann Clin Biochem; 2016 Mar; 53(Pt 2):240-51. PubMed ID: 25732129 [TBL] [Abstract][Full Text] [Related]
22. Binding of serum amyloid P component to heparin in human serum. Li XA; Hatanaka K; Guo L; Kitamura Y; Yamamoto A Biochim Biophys Acta; 1994 Nov; 1201(2):143-8. PubMed ID: 7947925 [TBL] [Abstract][Full Text] [Related]
23. Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. Zhang W; Xu W; Xiong S J Immunol; 2011 Aug; 187(4):1764-77. PubMed ID: 21753147 [TBL] [Abstract][Full Text] [Related]
24. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675 [TBL] [Abstract][Full Text] [Related]
25. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition. Maeda S Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037 [TBL] [Abstract][Full Text] [Related]
26. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594 [TBL] [Abstract][Full Text] [Related]
27. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component. Likó I; Mák M; Klement E; Hunyadi-Gulyás E; Pázmány T; Medzihradszky KF; Urbányi Z Neurosci Lett; 2007 Jan; 412(1):51-5. PubMed ID: 17141957 [TBL] [Abstract][Full Text] [Related]
28. Human serum amyloid P component binds to peripheral blood monocytes. Macdonald SL; Kilpatrick DC Scand J Immunol; 2006 Jul; 64(1):48-52. PubMed ID: 16784490 [TBL] [Abstract][Full Text] [Related]
29. [Amyloid P components in normal human skin and skin with lesions]. Hintner H; Breathnach SM Hautarzt; 1988 Nov; 39(11):712-6. PubMed ID: 3072321 [TBL] [Abstract][Full Text] [Related]
30. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. García de Frutos P; Dahlbäck B J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054 [TBL] [Abstract][Full Text] [Related]
31. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. Hawkins PN; Wootton R; Pepys MB J Clin Invest; 1990 Dec; 86(6):1862-9. PubMed ID: 2254450 [TBL] [Abstract][Full Text] [Related]
32. Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques. Mencarelli C; Bode GH; Losen M; Kulharia M; Molenaar PC; Veerhuis R; Steinbusch HW; De Baets MH; Nicolaes GA; Martinez-Martinez P J Biol Chem; 2012 Apr; 287(18):14897-911. PubMed ID: 22396542 [TBL] [Abstract][Full Text] [Related]
33. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Pepys MB; Rademacher TW; Amatayakul-Chantler S; Williams P; Noble GE; Hutchinson WL; Hawkins PN; Nelson SR; Gallimore JR; Herbert J Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5602-6. PubMed ID: 8202534 [TBL] [Abstract][Full Text] [Related]
34. The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa. Malm J; Sonesson A; Hellman J; Bjartell A; Frohm B; Hillarp A Int J Androl; 2008 Sep; 31(5):508-17. PubMed ID: 17822421 [TBL] [Abstract][Full Text] [Related]
35. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes. Brown MR; Anderson BE J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897 [TBL] [Abstract][Full Text] [Related]